Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia

E Olavarria, Shamyla Siddique, Michael Griffiths, S Avery, JL Byrne, Karen Piper, AL Lennard, Lalit Pallan, Julie Arrazi, JB Perz, D O'Shea, JM Goldman, JF Apperley, Charles Craddock

Research output: Contribution to journalArticle

83 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry